| |
| |
|
| Insider
Information: |
Mackaness James H |
| Relationship: |
|
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
108,005 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$119,574 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
108,005 |
|
|
| Total
Value |
$119,574 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -65.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iridex Corp |
IRIX |
CFO and COO |
2015-08-19 |
45,052 |
2009-03-13 |
0 |
Premium* |
|
|
Invuity, Inc. |
IVTY |
Chief Financial Officer |
2018-10-23 |
0 |
2016-05-18 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2024-04-01 |
62,953 |
2020-01-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
87 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-06-26 |
4 |
B |
$1.65 |
$9,999 |
D/D |
6,060 |
16,060 |
2.74 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-09-13 |
4 |
B |
$0.89 |
$9,981 |
D/D |
11,235 |
27,295 |
2.74 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
40,000 |
67,295 |
2.66 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
29,084 |
33,570 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-10-02 |
4 |
OE |
$1.75 |
$24,497 |
D/D |
8,309 |
41,879 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-11-28 |
4 |
S |
$27.03 |
$105,190 |
D/D |
(3,878) |
29,692 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-11-29 |
4 |
S |
$27.43 |
$116,986 |
D/D |
(4,203) |
25,489 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-11-30 |
4 |
S |
$28.65 |
$119,937 |
D/D |
(4,186) |
21,303 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-12-11 |
4 |
OE |
$2.60 |
$38,925 |
D/D |
15,000 |
44,610 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-12-11 |
4 |
S |
$35.49 |
$1,182,828 |
D/D |
(32,482) |
12,128 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
56,000 |
68,128 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
CHIEF FINANCIAL OFFICER |
• – – |
2024-04-01 |
4 |
S |
$41.12 |
$213,937 |
D/D |
(5,175) |
62,953 |
0 |
- |
|
87 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
